Dahap, Jiel Rica B.

HRN: 20-16-74  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2022
CEFUROXIME 1.5GM (VIAL)
05/12/2022
05/18/2022
IV
870
Q12 7 Days
Pneumonia
Waiting Final Action 
05/14/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/14/2022
05/20/2022
IVT
180MG
OD
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: